Study guide

Poisoning, toxidromes and antidote decisions

AMC CAT MCQ Examination AMC Part 1

Track your progress as you read

Finished sections get a check mark.

1 Acute Coronary Syndromes & ECG Localization

ACS recognition and ECG localisation Reperfusion and infarction complications

2 Heart Failure, Cardiogenic Shock & Cardiac Arrhythmias

Heart failure assessment and treatment Arrhythmias and conduction emergencies

3 Systemic Hypertension & Peripheral Vascular Disease

Blood pressure and cardiovascular risk Secondary hypertension and arterial disease

4 Valvular Heart Disease, Infective Endocarditis & Pericarditis

Aortic and mitral valve disease Endocarditis and pericardial emergencies

5 Asthma & COPD Acute Flares and Maintenance

Asthma and COPD diagnosis and maintenance Acute asthma and COPD exacerbations

6 Pneumonia, pleural disease and respiratory failure

Pneumonia and infected pleural collections Pulmonary embolism, effusions and pneumothorax Respiratory failure, ARDS and sepsis

7 GI bleeding, bowel inflammation and malabsorption

GI bleeding assessment and resuscitation Varices, ulcers, reflux and lower GI bleeding IBD patterns and severe colitis assessment IBD treatment, coeliac disease and IBS

8 Chronic Liver Disease, Cirrhosis Complications & Acute Hepatitis

Cirrhosis diagnosis and prognosis Decompensation, viral hepatitis and surveillance

9 Diabetes, thyroid and adrenal disease

Diabetes diagnosis and ongoing care DKA, HHS and complication monitoring Thyroid disease assessment Thyroid emergencies and adrenal disease

10 Acute Kidney Injury, Chronic Kidney Disease & Fluid/Electrolyte Emergencies

AKI and chronic kidney disease Potassium and sodium emergencies

11 Anaemias, Inflammatory Arthropathies & Geriatric Comprehensive Assessment

Anaemia, bruising and blood disorders Arthritis, autoimmune disease and geriatric care

12 Evaluation of the Acute Abdomen, Peritonitis & Appendicitis

Abdominal pain, peritonitis and resuscitation Appendicitis diagnosis and treatment Perforation and mesenteric ischaemia

13 Small and Large Bowel Obstruction & Colorectal Surgical Pathology

Small bowel obstruction Colonic obstruction, volvulus and cancer recognition Colorectal care, diverticulitis and anorectal symptoms

14 Gallbladder Disease, Biliary Tract Infections & Acute Pancreatitis

Gallstones and biliary obstruction Cholangitis and pancreatitis diagnosis Pancreatitis severity and treatment

15 Advanced Trauma Life Support, Primary Survey & Life-Threatening Thoracic Injuries

Trauma primary survey and adjuncts Chest trauma and immediate threats

16 Traumatic Brain Injury, Intracranial Haemorrhage & Spinal Cord Clearance

Head injury, imaging and haemorrhage Herniation and spinal cord injury

17 Major Fractures, Joint Dislocations & Acute Compartment Syndrome

Fracture assessment and open injuries Compartment syndrome, dislocations and pelvic injury

18 Thermal Burns, Haemorrhagic Shock Resuscitation & Surgical Wound Care

Burn assessment and fluid resuscitation Bleeding shock, wound care and tetanus

19 Aortic Aneurysms & Acute Arterial Limb Ischaemia

Aneurysm recognition and planned care Ruptured aneurysm and acute limb ischaemia

20 Urological Emergencies, Testicular Torsion & Haematuria Investigation

Retention, stones and obstructed infection Scrotal pain and haematuria

21 Preoperative Risk Stratification & Postoperative Surgical Complications

Preoperative assessment and medicines Postoperative complications and prevention

22 Early Pregnancy Bleeding, Ectopic Pregnancy & Antenatal Screening

Miscarriage and ectopic pregnancy Antenatal screening and early-pregnancy comparisons

23 Hypertensive Disorders of Pregnancy & Medical Complications in Pregnancy

Pregnancy hypertension and preeclampsia Eclampsia, HELLP and antepartum bleeding

24 Intrapartum Monitoring, Postpartum Haemorrhage & Obstetric Emergencies

Labour physiology and CTG assessment CTG response and postpartum haemorrhage Obstetric emergencies and preterm birth

25 Abnormal Uterine Bleeding, Pelvic Pain & Endometriosis

Abnormal bleeding and structural causes Endometrial sampling and endometriosis PCOS diagnosis and long-term care

26 Contraception, Emergency Contraception & Pregnancy Termination

Contraceptive choice and missed pills Emergency contraception and abortion

27 Australian Cervical Screening Program & Gynaecological Malignancies

Cervical screening and cervical cancer Endometrial and ovarian cancer

28 Neonatal Resuscitation, Congenital Conditions & Neonatal Jaundice

Newborn resuscitation, Apgar and cyanosis Neonatal jaundice assessment Jaundice treatment and congenital screening

29 Developmental Milestones, Growth Charts & Failure to Thrive

Developmental milestones Regression, autism and support Faltering growth and developmental comparisons

30 The Limping Child, Septic Arthritis vs Transient Synovitis & Paediatric Hip Conditions

Limp assessment and septic-joint risk Joint-infection management and Perthes disease SUFE and paediatric hip comparisons

31 Croup, Bronchiolitis, Paediatric Asthma & Anaphylaxis

Croup Bronchiolitis Paediatric asthma Paediatric anaphylaxis

32 Evaluation of the Febrile Child, Sepsis & Meningococcal Disease

Febrile neonates and young infants Meningococcal disease and paediatric sepsis Bacterial meningitis and CSF interpretation Kawasaki disease and follow-up

33 Paediatric Surgical Abdomen, Dehydration & Child Protection / Non-Accidental Injury

Pyloric stenosis Intussusception and dehydration Child protection and injury assessment

34 The Mental State Examination & Suicide Risk Stratification

Mental state examination and psychotic symptoms Suicide formulation and mental health law

35 Major Depressive Disorder, Bipolar Affective Disorder & Mood Stabilisers

Depression assessment and treatment Serotonin toxicity and bipolar presentations Mood stabilisers and ECT

36 Generalised Anxiety, Panic Disorder, PTSD & Obsessive-Compulsive Disorder

Anxiety, panic and agoraphobia OCD and trauma-related disorders

37 Schizophrenia, Acute Psychosis & Antipsychotic Management

Psychosis assessment and antipsychotics Clozapine and severe adverse effects

38 Substance Use Disorders & Acute Withdrawal Syndromes

Substance disorders and alcohol withdrawal Wernicke disease, opioids and stimulants

39 Delirium vs Dementia, Perinatal Mood Disorders & Paediatric Psychiatry

Delirium and dementia assessment Cognitive behaviour, perinatal and childhood psychiatry

40 Medicare, PBS, AHPRA & Good Medical Practice Framework

Australian health services and Medicare PBS access and professional registration Professional boundaries and notifications

41 Informed Consent (Rogers v Whitaker), Mental Capacity & Involuntary Treatment

Consent, material risks and young people Capacity, refusal and substitute decisions

42 Patient Privacy, Confidentiality Exceptions & Mandatory Notifications

Privacy, disclosure and child reporting Driving fitness and threat disclosure

43 First Nations health and preventive care

First Nations health, determinants and cultural safety Community care, Item 715 and CTG medicines Immunisation and cancer screening entry points Screening pathways and primary CVD prevention

44 Epidemiological Metrics, Clinical Study Designs & Notifiable Communicable Diseases

Epidemiology, calculations, bias and surveillance

45 Neurological presentations

Stroke, TIA and focal weakness Headache, facial pain and vertigo Seizures, collapse and altered consciousness Numbness, movement disorders and generalised weakness

46 Musculoskeletal pain

Back, neck, bone and soft tissue pain

47 Eye presentations

Altered vision and retinal disease Red eye, ocular injury and discharge

48 Ear, nose, throat and oral health

Ear pain, hearing loss and tinnitus Nasal problems, neck lumps, hoarseness and dysphagia Toothache, mouth symptoms, dry mouth and halitosis

49 Skin, hair and nails

Rash, itch, infection and skin ulcers Skin lesions, hair loss and nail abnormalities

50 Breast health and feeding

Breast lumps, discharge and breastfeeding problems

51 Sexual and reproductive presentations

Genital symptoms, discharge and pelvic infection Menopause, prolapse and urinary symptoms Infertility and sexual dysfunction

52 Palliative care and carers

The dying patient, symptoms and carers

53 Eating disorders and personality care

Eating disorders, obesity and weight change Personality difficulties, self-harm and complex care

54 Sleep presentations

Insomnia, snoring and daytime sleepiness

55 Poisoning, resuscitation and environmental emergencies

Poisoning, toxidromes and antidote decisions Cardiopulmonary arrest, choking and emergency help Bites, stings, heat, cold and drowning

56 Communication, rights and professional practice

Communication, handover, errors and complaints Healthcare rights, inclusive care and equitable access Certificates, deaths, CPD and supervision Telehealth, images, prescribing and doctors' health

57 Genetics, research and donation

Genetic testing, research and organ donation

58 Travel, fever and outbreaks

Fever, travellers and outbreak response

Poisoning, toxidromes and antidote decisions

Key Takeaways Explain This Topic AI

Contact the Australian Poisons Information Centre on 13 11 26 for specific advice.

An early paracetamol concentration cannot exclude toxicity before the appropriate sampling time.

Activated charcoal is selective treatment and requires attention to airway safety.

Last updated: October 2026

Stabilise and identify the exposure

Assess airway, breathing, circulation, glucose, temperature and mental state before pursuing a detailed toxicology history. Call the Australian Poisons Information Centre on 13 11 26 for exposure-specific advice and involve a clinical toxicologist for serious cases. Ask the product, formulation, maximum possible amount, time, route, co-ingestants and relevant comorbidities. Obtain packaging where safely available. The patient's estimate may be incomplete, particularly after deliberate self-poisoning. Modified-release preparations and long-acting substances can produce delayed toxicity despite an initially normal examination.

Use ECG and directed blood tests according to the possible poison. QRS widening, QT prolongation, bradycardia or arrhythmia can identify urgent cardiotoxicity. A routine urine drug screen has limited coverage and can be falsely positive or remain positive after intoxication resolves. It must not overrule the clinical syndrome. Protect staff and the patient from secondary exposure after chemical contamination. Skin/eye irrigation and decontamination may be immediate priorities; avoid transferring contaminated clothing into an unprepared clinical area.

Recognise toxidromes

Opioid toxicity causes reduced ventilation and consciousness, often with small pupils. Support ventilation and give titrated naloxone when indicated; awakening is not the sole endpoint. Long-acting exposure may require an infusion and prolonged monitoring because naloxone wears off earlier. Sedative co-ingestion may leave persistent impairment. Sympathomimetic toxicity can produce agitation, sweating, hypertension and hyperthermia; benzodiazepines, cooling and complication assessment are central. Anticholinergic toxicity can look similar but often has dry skin/mouth and urinary retention; specific antidote use needs toxicology advice.

Cholinergic poisoning can cause secretions, bronchospasm, diarrhoea, small pupils and weakness. Protect staff and use the organophosphate-specific pathway where relevant. Serotonin toxicity often features clonus and hyperreflexia after relevant medicines, while NMS commonly causes rigidity with dopamine-blocking exposure. These are clinical patterns, not diagnoses established by one temperature reading. Treat hyperthermia actively, stop triggers and seek specialist care. A delirious agitated patient may also have infection, hypoglycaemia or head injury, which must not be missed because a substance history is present.

Paracetamol and common medicines

Paracetamol poisoning can initially be asymptomatic. Assess it in deliberate adolescent/adult self-poisoning and consider combination products. For a single immediate-release ingestion at a known time, a concentration at or after four hours is interpreted with the treatment nomogram and the current Australian pathway. An earlier low level cannot safely exclude toxicity. Unknown time, repeated supratherapeutic dosing and modified-release exposure require different algorithms and often repeat levels. Acetylcysteine is time-sensitive; do not delay indicated treatment while awaiting a result that will arrive late.

Monitor liver tests, INR, kidney function and concentrations as specified, and use protocol criteria for stopping or extending acetylcysteine. A completed standard infusion does not automatically prove treatment can stop. Tricyclic poisoning can cause seizures, hypotension and QRS widening, needing sodium bicarbonate and monitored specialist care when indicated. Salicylate poisoning can cause tinnitus, vomiting, tachypnoea and mixed acid–base disturbance; levels and clinical status may warrant alkalinisation or dialysis. Avoid assuming a normal pH means there is no serious acid–base problem.

Decontamination and special exposures

Activated charcoal is used only for selected substances and time frames with a safe airway and toxicology advice. It is not routine for every ingestion and is unsuitable for some exposures. Do not induce vomiting or use gastric lavage as a universal first step. Caustic ingestion requires airway/GI assessment and advice; avoid neutralisation attempts that create heat or further injury. Hydrocarbon aspiration risk can dominate management even when the swallowed volume is small. A battery or magnet ingestion follows a foreign-body pathway rather than a standard medicine-overdose algorithm.

Carbon monoxide can produce headache, nausea, confusion and collapse, sometimes affecting several people in one environment. Standard pulse oximetry can be misleading; assess exposure and co-oximetry where appropriate, give indicated oxygen and obtain expert advice. Cyanide risk may coexist in severe enclosed-space fires. Toxic alcohols can cause delayed metabolic acidosis and organ injury; antidote and dialysis decisions are time-sensitive. Do not wait for every specialised assay before seeking advice when the clinical/exposure pattern is concerning.

Disposition and self-harm care

Observation duration follows the substance, formulation, clinical course and treatment, not one universal six-hour rule. Consider delayed cardiac, respiratory and hepatic effects. Deliberate self-poisoning needs a psychosocial assessment and an individual safety plan after stabilisation, with assessment of current intent, supports and access to means. A statement of regret does not replace that assessment. Check safeguarding for children and vulnerable adults, including accidental dosing errors and access to medicines at home.

For example, an apparently well patient presents two hours after a potentially large paracetamol ingestion. Arrange the correctly timed concentration and guideline-based treatment assessment; do not discharge from an early low level. A drowsy patient after methadone may re-sedate after naloxone and needs prolonged monitored care. Record exposure uncertainties, advice received, treatment endpoints and handover responsibilities so the next clinician knows what still needs checking.

RCH paracetamol poisoning .

Review checkpoints

Contact the Australian Poisons Information Centre on 13 11 26 for specific advice.

An early paracetamol concentration cannot exclude toxicity before the appropriate sampling time.

Activated charcoal is selective treatment and requires attention to airway safety.